Identification of exosomal microRNAs and related hub genes associated with imatinib resistance in chronic myeloid leukemia.

Autor: Karabay AZ; Department of Biochemistry, Faculty of Pharmacy, Ankara University, Ankara, Turkey. akarabay@ankara.edu.tr., Ozkan T; Department of Medical Biology, Faculty of Medicine, Ankara University, Ankara, Turkey. tozkan@ankara.edu.tr., Karadag Gurel A; Department of Medical Biology, Faculty of Medicine, Usak University, Usak, Turkey. aynur.karadag@usak.edu.tr., Koc A; Department of Biochemistry, Faculty of Pharmacy, Ankara University, Ankara, Turkey., Hekmatshoar Y; Department of Medical Biology, Faculty of Medicine, Altinbas University, Istanbul, Turkey., Sunguroglu A; Department of Medical Biology, Faculty of Medicine, Ankara University, Ankara, Turkey., Aktan F; Department of Biochemistry, Faculty of Pharmacy, Ankara University, Ankara, Turkey., Buyukbingöl Z; Department of Biochemistry, Faculty of Pharmacy, Ankara University, Ankara, Turkey.

Publikováno v: Naunyn-Schmiedeberg's archives of pharmacology [Naunyn Schmiedebergs Arch Pharmacol] 2024 Dec; Vol. 397 (12), pp. 9701-9721. Date of Electronic Publication: 2024 Jun 25.

Phenotypic and functional characterization of subpopulation of Imatinib resistant chronic myeloid leukemia cell line.

Autor: Hekmatshoar Y; Department of Medical Biology, School of Medicine, Altinbas University, Istanbul, Turkey; Department of Medical Biology, School of Medicine, Ankara University, Ankara, Turkey. Electronic address: yalda.hekmatshoar@altinbas.edu.tr., Karadag Gurel A; Department of Medical Biology, School of Medicine, Usak University, Usak, Turkey. Electronic address: aynur.karadag@usak.edu.tr., Ozkan T; Department of Medical Biology, School of Medicine, Ankara University, Ankara, Turkey., Rahbar Saadat Y; Kidney Research Center, Tabriz University of Medical Sciences, Tabriz, Iran., Koc A; Faculty of Pharmacy, Department of Biochemistry, Ankara University, Ankara, Turkey., Karabay AZ; Faculty of Pharmacy, Department of Biochemistry, Ankara University, Ankara, Turkey., Bozkurt S; Department of Medical Biology, School of Medicine, Istinye University, Istanbul, Turkey., Sunguroglu A; Department of Medical Biology, School of Medicine, Ankara University, Ankara, Turkey.

Publikováno v: Advances in medical sciences [Adv Med Sci] 2023 Sep; Vol. 68 (2), pp. 238-248. Date of Electronic Publication: 2023 Jul 06.

Assessment of azithromycin as an anticancer agent for treatment of imatinib sensitive and resistant CML cells.

Autor: Ozkan T; Department of Medical Biology, School of Medicine, Ankara University, Ankara, Turkey. Electronic address: tozkan@ankara.edu.tr., Hekmatshoar Y; Department of Medical Biology, School of Medicine, Ankara University, Ankara, Turkey. Electronic address: hekmatshoar@ankara.edu.tr., Karabay AZ; Faculty of Pharmacy, Department of Biochemistry, Ankara University, Ankara, Turkey., Koc A; Faculty of Pharmacy, Department of Biochemistry, Ankara University, Ankara, Turkey., Altinok Gunes B; Vocational School of Health Services, Medical Laboratory Techniques, Ankara University, Ankara, Turkey., Karadag Gurel A; Department of Medical Biology, School of Medicine, Usak University, Usak, Turkey., Sunguroglu A; Department of Medical Biology, School of Medicine, Ankara University, Ankara, Turkey.

Publikováno v: Leukemia research [Leuk Res] 2021 Mar; Vol. 102, pp. 106523. Date of Electronic Publication: 2021 Feb 06.

Synthesis of Some Benzimidazole-derived Molecules and their Effects on PARP-1 Activity and MDA-MB-231, MDA-MB-436, MDA-MB-468 Breast Cancer Cell Viability.

Autor: Gurkan-Alp AS; Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Ankara University, 06560 Tandogan, Ankara, Turkey., Alp M; Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Ankara University, 06560 Tandogan, Ankara, Turkey., Karabay AZ; Department of Biochemistry, Faculty of Pharmacy, Ankara University, 06560 Tandogan, Ankara, Turkey., Koc A; Department of Biochemistry, Faculty of Pharmacy, Ankara University, 06560 Tandogan, Ankara, Turkey., Buyukbingol E; Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Ankara University, 06560 Tandogan, Ankara, Turkey.

Publikováno v: Anti-cancer agents in medicinal chemistry [Anticancer Agents Med Chem] 2020; Vol. 20 (14), pp. 1728-1738.

Characterization of imatinib-resistant K562 cell line displaying resistance mechanisms.

Autor: Hekmatshoar Y; Department of Medical Biology, School of Medicine, Ankara University, Ankara, Turkey., Ozkan T; Department of Medical Biology, School of Medicine, Ankara University, Ankara, Turkey., Altinok Gunes B; Department of Medical Biology, School of Medicine, Ankara University, Ankara, Turkey., Bozkurt S; Department of Medical Biology, School of Medicine, Istinye University, Istanbul, Turkey., Karadag A; Department of Medical Biology, School of Medicine, Ankara University, Ankara, Turkey., Karabay AZ; Faculty of Pharmacy, Department of Biochemistry, Ankara University, Ankara, Turkey., Sunguroglu A; Department of Medical Biology, School of Medicine, Ankara University, Ankara, Turkey.

Publikováno v: Cellular and molecular biology (Noisy-le-Grand, France) [Cell Mol Biol (Noisy-le-grand)] 2018 May 15; Vol. 64 (6), pp. 23-30. Date of Electronic Publication: 2018 May 15.